Analysis of high-grade glioma (HGG) indicated that E2F2 and E2F8 are highly correlated with oncogenes driving proliferation and therapeutic resistance and E2F8 independently predicts poorer survival [92]. Here, E2F2 is linked to central nervous system cancer.